These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26405311)

  • 1. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration.
    Sullivan T; Forest JM; Leclair G
    Hosp Pharm; 2015 Mar; 50(3):214-20. PubMed ID: 26405311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of Lactated Ringer's Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
    Vallée M; Barthélémy I; Friciu M; Pelletier É; Forest JM; Benoit F; Leclair G
    Hosp Pharm; 2021 Aug; 56(4):228-234. PubMed ID: 34381254
    [No Abstract]   [Full Text] [Related]  

  • 3. Compatibility of Y-Site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
    Lessard JJ; Caron E; Schérer H; Forest JM; Leclair G
    Hosp Pharm; 2020 Oct; 55(5):332-337. PubMed ID: 32999503
    [No Abstract]   [Full Text] [Related]  

  • 4. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility screening of precedex during simulated y-site administration with other drugs.
    Trissel LA; Saenz CA; Ingram DS; Williams KY; Retzinger JP
    Int J Pharm Compd; 2002; 6(3):230-3. PubMed ID: 23979190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility screening of bivalirudin during simulated y-site administration with other drugs.
    Trissel LA; Saenz CA
    Int J Pharm Compd; 2002; 6(4):311-5. PubMed ID: 23979308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility of micafungin injection with other drugs during simulated y-site co-administration.
    Trusley C; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2006; 10(3):230-3. PubMed ID: 23974236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Feb; 51(4):495-9. PubMed ID: 8017415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
    Teibel HM; Knoderer CA; Nichols KR
    Hosp Pharm; 2015 Sep; 50(8):710-3. PubMed ID: 26823620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Mar; 51(5):672-8. PubMed ID: 8203388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of doripenem with other drugs during simulated Y-site administration.
    Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D
    Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of caspofungin acetate injection with other drugs simulated y-site coadministration.
    Chan P; Heatherly K; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2008; 12(3):276-8. PubMed ID: 23969719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incompatibilities of lansoprazole injection with other drugs during simulated y-site coadministration.
    Trissel LA; Saenz C; Williams KY; Ingram D
    Int J Pharm Compd; 2001; 5(4):314-9. PubMed ID: 23981922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility screening of hextend during simulated y-site administration with other drugs.
    Trissel LA; Williams KY; Baker MB
    Int J Pharm Compd; 2001; 5(1):69-72. PubMed ID: 23981801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jun; 54(11):1287-92. PubMed ID: 9179349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
    Trissel LA; Saenz CA; Ogundele AB; Ingram DS
    Am J Health Syst Pharm; 2004 Nov; 61(21):2289-93. PubMed ID: 15552637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
    Correard F; Savry A; Gauthier-Villano L; Pisano P; Pourroy B
    Am J Health Syst Pharm; 2014 Aug; 71(15):1288-91. PubMed ID: 25027536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.